candesartan cilexetil + rosuvastatin

**Candesartan cilexetil + rosuvastatin** is a fixed-dose oral combination product consisting of two pharmaceuticals: candesartan cilexetil, an angiotensin II receptor blocker (ARB), and rosuvastatin, a statin that inhibits 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase. This combination is indicated for the prevention and management of cardiovascular diseases, including atherosclerosis, hypertension, and hypercholesterolemia. Candesartan cilexetil lowers blood pressure by antagonizing the angiotensin II type 1 receptor, preventing vasoconstriction and aldosterone secretion. Rosuvastatin effectively lowers LDL cholesterol and overall cardiovascular risk by inhibiting hepatic cholesterol biosynthesis. The combination aims to synergistically reduce major cardiovascular events and improve patient compliance by simplifying dosing regimens[5][3][7].

Brand names

Sinlip Prevent

Other names

DP-R208DP-R-208DP-R 208